BioCentury
ARTICLE | Financial News

PDL BioPharma financial update

September 9, 2013 7:00 AM UTC

PDL BioPharma amended the conversion rates for its outstanding convertible senior notes in connection with its regular dividend to be paid on Sept. 12 to stockholders of record on Sept. 5. The 2.875% ...